Literature DB >> 10727879

Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine.

S Michael1, M Thöle, R Dillmann, A Fahr, J Drewe, G Fricker.   

Abstract

The potential of the nontoxic bile salt derivative, cholylsarcosine, to enhance the intestinal absorption of peptides was investigated in vitro and in situ. The permeation of the two model peptides octreotide and vasopressin-[arg(8)CT>/=CS, whereas ursodeoxycholic acid exhibited no absorption enhancement. Determination of the cytotoxic potential of the bile salts revealed the same rank order. In rats, octreotide and desmopressin were absorbed from the gastrointestinal-tract with moderate absorption efficiency. Coadministration of bile salts resulted in an increased absorption efficiency. The effect of CS was similar to that of CT. In conclusion, CS shows absorption enhancement properties and a relatively low cytotoxicity. It offers an alternative as absorption enhancer as compared to conventional bile acids which may have a potential cocarcinogenic risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727879     DOI: 10.1016/s0928-0987(99)00093-7

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  12 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

2.  Fasting increases tobramycin oral absorption in mice.

Authors:  Luigina De Leo; Nicola Di Toro; Giuliana Decorti; Noelia Malusà; Alessandro Ventura; Tarcisio Not
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

3.  Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates.

Authors:  Ok-Cheol Jeon; Seung Rim Hwang; Taslim A Al-Hilal; Jin Woo Park; Hyun Tae Moon; Seulki Lee; Jae Hyung Park; Youngro Byun
Journal:  Pharm Res       Date:  2013-01-05       Impact factor: 4.200

4.  A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine.

Authors:  S Lee; J Lee; D Y Lee; S K Kim; Y Lee; Y Byun
Journal:  Diabetologia       Date:  2005-03-01       Impact factor: 10.122

Review 5.  Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents.

Authors:  M Mikov; J P Fawcett; K Kuhajda; S Kevresan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

6.  Structure and dynamics of cholic acid and dodecylphosphocholine-cholic acid aggregates.

Authors:  Abdallah Sayyed-Ahmad; Lenard M Lichtenberger; Alemayehu A Gorfe
Journal:  Langmuir       Date:  2010-08-17       Impact factor: 3.882

7.  Membranolytic activity of bile salts: influence of biological membrane properties and composition.

Authors:  Patrick Garidel; Annegret Hildebrand; Katja Knauf; Alfred Blume
Journal:  Molecules       Date:  2007-10-23       Impact factor: 4.411

8.  Influence of sodium monoketocholate on the hypolipidemic activity of lovastatin in healthy and diabetic rats.

Authors:  Suncica Kojic-Damjanov; Mirjana Djeric; Momir Mikov; Ksenija Kuhajda; Slavko Kevresan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Apr-Jun       Impact factor: 2.441

9.  Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate microvesicles in rat.

Authors:  Svetlana Golocorbin-Kon; Momir Mikov; Mousab Arafat; Zika Lepojevic; Ivan Mikov; Majda Sahman-Zaimovic; Zdenko Tomic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jan-Mar       Impact factor: 2.569

10.  A drug delivery strategy: binding enkephalin to asialoglycoprotein receptor by enzymatic galactosylation.

Authors:  Michelle P Christie; Pavla Simerská; Freda E-C Jen; Waleed M Hussein; Mohamad F M Rawi; Lauren E Hartley-Tassell; Christopher J Day; Michael P Jennings; Istvan Toth
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.